HuMurine Technologies

HuMurine Technologies was a private biotechnology and preclinical CRO company focused on commercializing humanized immune system mouse models for drug discovery and translational research. The company’s core offerings centered on its Hu-M mouse and related humanized NOG-based models, which were designed to support efficacy and safety testing of immuno-oncology agents, gene therapies, and hematopoiesis-promoting agents. HuMurine positioned itself as a bridge between academic humanized-mouse know-how and commercial preclinical services for biopharma customers. The company also pursued grant-funded platform development, including patient-derived xenograft and humanized mouse combinations for immunotherapy evaluation. Public web evidence suggests the business became inactive and its original website is no longer operating as the company site.